These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sex differences in survival from cutaneous melanoma. Rampen FH Int J Dermatol; 1984 Sep; 23(7):444-52. PubMed ID: 6386712 [TBL] [Abstract][Full Text] [Related]
3. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496 [TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma: sex differences in survival after evidence of distant metastasis. Rampen F Br J Cancer; 1980 Jul; 42(1):52-7. PubMed ID: 7426329 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemically detectable bcl-2 expression in metastatic melanoma: association with survival and treatment response. Vlaykova T; Talve L; Hahka-Kemppinen M; Hernberg M; Muhonen T; Collan Y; Pyrhönen S Oncology; 2002; 62(3):259-68. PubMed ID: 12065874 [TBL] [Abstract][Full Text] [Related]
10. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. Petersen RP; Hanish SI; Haney JC; Miller CC; Burfeind WR; Tyler DS; Seigler HF; Wolfe W; D'Amico TA; Harpole DH J Thorac Cardiovasc Surg; 2007 Jan; 133(1):104-10. PubMed ID: 17198792 [TBL] [Abstract][Full Text] [Related]
11. Proliferation rates in human malignant melanoma: relationship to clinicopathological features and outcome. Laing JH; Wilson GD; Martindale CA Melanoma Res; 2003 Jun; 13(3):271-7. PubMed ID: 12777982 [TBL] [Abstract][Full Text] [Related]
15. Survival after surgical resection of isolated pulmonary metastases from malignant melanoma. Andrews S; Robinson L; Cantor A; DeConti RC Cancer Control; 2006 Jul; 13(3):218-23. PubMed ID: 16885918 [TBL] [Abstract][Full Text] [Related]
16. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors. Tas F; Erturk K Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368 [TBL] [Abstract][Full Text] [Related]
17. Tissue inhibitor of metalloproteinase-3 (TIMP3) expression decreases during melanoma progression and inhibits melanoma cell migration. Das AM; Bolkestein M; van der Klok T; Oude Ophuis CM; Vermeulen CE; Rens JA; Dinjens WN; Atmodimedjo PN; Verhoef C; Koljenović S; Smits R; Ten Hagen TL; Eggermont AM Eur J Cancer; 2016 Oct; 66():34-46. PubMed ID: 27522248 [TBL] [Abstract][Full Text] [Related]
18. Overall survival and PD-L1 expression in metastasized malignant melanoma. Gadiot J; Hooijkaas AI; Kaiser AD; van Tinteren H; van Boven H; Blank C Cancer; 2011 May; 117(10):2192-201. PubMed ID: 21523733 [TBL] [Abstract][Full Text] [Related]
19. [Late metastasis in malignant melanoma of the skin]. Landthaler M; Braun-Falco O; Schlamminger F; Schubert-Fritschle G Dtsch Med Wochenschr; 1989 Jul; 114(30):1149-52. PubMed ID: 2752919 [TBL] [Abstract][Full Text] [Related]
20. Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma Registry. Gassenmaier M; Keim U; Leiter U; Eigentler TK; Röcken M; Gesierich A; Moritz RKC; Heinzerling L; Tüting T; Wollina U; Garbe C J Am Acad Dermatol; 2019 May; 80(5):1299-1307.e7. PubMed ID: 30703453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]